1,n(6)-ethenoadenosine diphosphate has been researched along with yo-pro 1 in 1 studies
Studies (1,n(6)-ethenoadenosine diphosphate) | Trials (1,n(6)-ethenoadenosine diphosphate) | Recent Studies (post-2010) (1,n(6)-ethenoadenosine diphosphate) | Studies (yo-pro 1) | Trials (yo-pro 1) | Recent Studies (post-2010) (yo-pro 1) |
---|---|---|---|---|---|
37 | 0 | 0 | 122 | 1 | 51 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liao, SD; Puro, DG | 1 |
1 other study(ies) available for 1,n(6)-ethenoadenosine diphosphate and yo-pro 1
Article | Year |
---|---|
NAD+-induced vasotoxicity in the pericyte-containing microvasculature of the rat retina: effect of diabetes.
Topics: Adenosine Diphosphate; Adenosine Diphosphate Ribose; ADP Ribose Transferases; Animals; Apoptosis; Benzoxazoles; Cell Membrane Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Fluorescent Dyes; Microscopy, Fluorescence; NAD; Pericytes; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Rats; Rats, Long-Evans; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Retinal Vessels | 2006 |